9th Annual SPECT-CT symposium virtual event

4th February 2022  09:45 - 16:10 (GMT+00:00) GMT

Virtual event – Friday 4 February

09:45-16:10 GMT

5 CPD points


The SPECT-CT course is the only course that is solely dedicated to the clinical usage of SPECT-CT. This successful and popular course, now running virtually for the 9th time, has experts within the field of SPECT-CT giving all aspects of SPECT-CT usage from guidance and best practices to new and updated uses within the specialty. It is the only course that will provide you with comprehensive teaching and information for a successful delivery of SPECT-CT service. This virtual course will benefit everyone who is involved in SPECT-CT service delivery.


View programme here



With thanks to our sponsors:




Registration fees:


Non-members £140

World Partner Network members £95

BIR Plan 1 members £95

BIR Plan 2 members £85

BIR International members £85

BIR Trainee members £85

BIR Retired / Student members £65


Payment for all events must be made via a debit or credit card. Invoices and PO numbers cannot be used for registration payment. If you need your hospital, Trust, or organisation to pay for registration fees please have them contact our events team at conference@bir.org.uk. For any further inquiries please contact conference@bir.org.uk


If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email conference@bir.org.uk 


Please ensure that you have read the events terms and conditions here, before booking onto an event. 




Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.


Alnylam is leading the translation of RNA interference (RNAi) into a whole class of innovative medicines with the potential to help patients who have limited or inadequate treatment options live fuller, healthier lives. Patients are at the core of everything we do; their needs drive our discoveries and their stories further our commitment to delivering innovative therapies.

Bayer Healthcare

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk


Curium is the world’s largest nuclear medicine company. We develop, manufacture and distribute world-class radiopharmaceutical products to help patients around the globe. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence and unparalleled service. To learn more, visit www.curiumpharma.com

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare

Siemens Healthineers

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. Further information is available at www.siemens-healthineers.co.uk.